Taysha Gene Therapies, Inc. (TSHA)
USD 1.26
(7.26%)
USD 1.26
(7.26%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|
| Operating Cash Flow | -73.01 Million | -88.39 Million | -117.04 Million | -30.72 Million | 135 Thousand |
| Net Income | -111.56 Million | -166.01 Million | -174.52 Million | -60.01 Million | -4.46 Million |
| Depreciation & Amortization | 1.37 Million | 1.17 Million | 492 Thousand | 9000.00 | - |
| Deferred income taxes | 2.29 Million | - | - | - | - |
| Stock-based compensation | 7.9 Million | 18.04 Million | 18.18 Million | 3.35 Million | - |
| Change in working capital | -18.01 Million | 18.51 Million | 28.66 Million | -111 Thousand | 540 Thousand |
| Other non-cash items | 44.98 Million | 39.89 Million | 10.13 Million | 26.03 Million | 3.92 Million |
| Investing Cash Flow | -7.35 Million | -24.93 Million | -21.55 Million | -9.08 Million | - |
| Investments in PPE | -7.36 Million | -24.86 Million | -21.55 Million | -9.08 Million | - |
| Acquisitions | - | - | - | - | - |
| Investment purchases | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - |
| Other Investing Activities | 17 Thousand | -61 Thousand | -6.25 Million | -9 Million | - |
| Financing Cash Flow | 136.39 Million | 52.09 Million | 39.08 Million | 291.06 Million | - |
| Debt repayment | -3.84 Million | - | -39.95 Million | -1.67 Million | - |
| Dividends payments | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - |
| Common Stock Issuance | 140.47 Million | 53.24 Million | -360 Thousand | 165.85 Million | - |
| Other Financing Activities | -229 Thousand | -1.14 Million | 79.4 Million | 126.88 Million | - |
| Accounts receivables | - | - | - | - | - |
| Accounts payables | -2.29 Million | -7.8 Million | 14.49 Million | 1.96 Million | - |
| Inventory | - | - | - | - | - |
| Other working capital | -15.71 Million | 26.32 Million | 14.17 Million | -2.07 Million | 540 Thousand |
| Cash at beginning of period | 87.88 Million | 151.74 Million | 251.25 Million | - | - |
| Cash at end of period | 144.38 Million | 90.51 Million | 151.74 Million | 251.25 Million | 135 Thousand |
| Capital Expenditure | -7.36 Million | -24.86 Million | -21.55 Million | -9.08 Million | - |
| Effect of forex changes on cash | 486 Thousand | - | - | - | - |
| Net cash flow / Change in cash | 56.5 Million | -61.22 Million | -99.51 Million | 251.25 Million | 135 Thousand |
| Free Cash Flow | -80.38 Million | -113.25 Million | -138.59 Million | -39.81 Million | 135 Thousand |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -20.92 Million | -24.06 Million | 47.74 Million | -111.56 Million | -117.08 Million | -24.59 Million |
| Depreciation & Amortization | 300 Thousand | 325 Thousand | 366 Thousand | 1.37 Million | 331 Thousand | 343 Thousand |
| Deferred income taxes | - | - | -3.93 Million | 2.29 Million | 101.07 Million | - |
| Stock-based compensation | 3.33 Million | 3.19 Million | 1.96 Million | 7.9 Million | 2.04 Million | 2.22 Million |
| Change in working capital | -4.28 Million | 298 Thousand | -4.84 Million | -18.01 Million | -7.37 Million | -796 Thousand |
| Other non-cash items | 5.62 Million | 292 Thousand | -57.41 Million | 44.98 Million | 3.06 Million | 4.06 Million |
| Investing Cash Flow | -201 Thousand | -140 Thousand | -10 Thousand | -7.35 Million | -3.49 Million | 48 Thousand |
| Investments in PPE | -201 Thousand | -140 Thousand | -17 Thousand | -7.36 Million | -3.5 Million | 48 Thousand |
| Acquisitions | - | - | - | - | - | - |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | - | - | 7000.00 | 17 Thousand | 10 Thousand | - |
| Financing Cash Flow | 70.46 Million | -4000.00 | -4.24 Million | 136.39 Million | 140.63 Million | 377 Thousand |
| Debt repayment | - | - | -3.84 Million | -3.84 Million | - | - |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | -423 Thousand | - | - | - |
| Common Stock Issuance | 70.48 Million | 26 Thousand | 77 Thousand | 140.47 Million | 140.71 Million | 500 Thousand |
| Other Financing Activities | -13 Thousand | -30 Thousand | -476 Thousand | -229 Thousand | -79 Thousand | -123 Thousand |
| Accounts receivables | - | - | - | - | - | - |
| Accounts payables | -1.61 Million | 3.98 Million | -1.23 Million | -2.29 Million | -3.18 Million | 1.76 Million |
| Inventory | - | - | - | - | - | - |
| Other working capital | -2.66 Million | -3.68 Million | -3.61 Million | -15.71 Million | -4.18 Million | -2.56 Million |
| Cash at beginning of period | 124.42 Million | 144.38 Million | 164.27 Million | 87.88 Million | 47.72 Million | 66.06 Million |
| Cash at end of period | 173.19 Million | 124.42 Million | 144.38 Million | 144.38 Million | 166.91 Million | 47.72 Million |
| Capital Expenditure | -201 Thousand | -140 Thousand | -17 Thousand | -7.36 Million | -3.5 Million | 48 Thousand |
| Effect of forex changes on cash | - | - | 486 Thousand | 486 Thousand | -236.28 Million | -6.25 Million |
| Net cash flow / Change in cash | 48.76 Million | -19.96 Million | -19.88 Million | 56.5 Million | 119.19 Million | -18.34 Million |
| Free Cash Flow | -21.7 Million | -19.95 Million | -16.13 Million | -80.38 Million | -21.44 Million | -18.71 Million |
5608
605488
BMTM
300724
WRT1V
1205